 |
Top 28 Gastroenterology startups
Oct 25, 2024 | By Jason Kwon | 20 |
Gastroenterology startups are developing solutions such as AI-powered diagnostic algorithms, capsule endoscopy, smart pills for targeted drug delivery, virtual colonoscopy, fecal microbiota transplantation, robotic-assisted surgery, etc.
1
Country: New Zealand | Funding: $18M
Alimetry develops Gastric Alimetry system is medical device which performs Body Surface Gastric Mapping. It is intended to record, store, view and process gastric electrophysiology as an aid in the diagnosis of various gastric disorders.
Alimetry develops Gastric Alimetry system is medical device which performs Body Surface Gastric Mapping. It is intended to record, store, view and process gastric electrophysiology as an aid in the diagnosis of various gastric disorders.
2
Country: USA | Funding: $1.6M
Kiwi Bio aims to free irritable bowel syndrome sufferers from restrictive diets. Kiwi’s product FODZYME uses patent-pending enzymes to break down common digestive triggers.
Kiwi Bio aims to free irritable bowel syndrome sufferers from restrictive diets. Kiwi’s product FODZYME uses patent-pending enzymes to break down common digestive triggers.
3
Country: USA | Funding: $1B
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
4
Country: USA | Funding: $537.8M
Seres Therapeutics is creating a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis
Seres Therapeutics is creating a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis
5
Country: USA | Funding: $441.6M
Ventyx Biosciences develops a drug for inflammatory bowel disease
Ventyx Biosciences develops a drug for inflammatory bowel disease
6
Country: USA | Funding: $407.2M
Synergy is a gastrointestinal-focused biopharmaceutical company committed to science-based innovation, providing novel treatment options for patients and healthcare providers, rewarding opportunities for our employees, and creating exceptional value for our shareholders.
Synergy is a gastrointestinal-focused biopharmaceutical company committed to science-based innovation, providing novel treatment options for patients and healthcare providers, rewarding opportunities for our employees, and creating exceptional value for our shareholders.
7
Country: USA | Funding: $198.4M
Allurion Technologies develops a medical device for weight loss that can be delivered and removed without surgery or endoscopy.
Allurion Technologies develops a medical device for weight loss that can be delivered and removed without surgery or endoscopy.
8
Country: USA | Funding: $173M
Metacrine is an emerging biotech company focused on developing best-in-class therapies to benefit patients with liver, gastrointestinal, and metabolic diseases.
Metacrine is an emerging biotech company focused on developing best-in-class therapies to benefit patients with liver, gastrointestinal, and metabolic diseases.
9
Country: USA | Funding: $105.6M
CapsoVision is a medical device company developing gastrointestinal medical devices.
CapsoVision is a medical device company developing gastrointestinal medical devices.
10
Country: USA | Funding: $60M
Oshi Health is a virtual-first medical practice revolutionizing the diagnosis, management and treatment of digestive health conditions.
Oshi Health is a virtual-first medical practice revolutionizing the diagnosis, management and treatment of digestive health conditions.
